-
-
Call more information
660-596-2224 -
ASA Monitor February 2021, Vol. 85, 11–12. Special thanks to Aubrey Samost-Williams, MD, for her contributions to this article. CASE 2021-2: Systems Problem An urgent caesarean section presented to the OR when one of the narcotic dispensing drawers was unable to be closed. This disabled the entire cart, which was a combined automated medication dispensing system […]
Read MoreAuthor: Beverly K. Philip MD FACA, FASA President of ASA Monday Morning Outreach We now have three weeks’ worth of data from our insurance carrier survey, where we’re learning about unilateral reduction in payments and contract terminations from some of you. We will use this data to advocate on behalf of our many members and […]
Read MoreAUTHORS: Lee, Hye-Mi MD et al Anesthesia & Analgesia: November 2020 BACKGROUND: Extensive efforts have been made toward reducing postoperative opioid use in children. In this study, we assessed whether propacetamol, or a nonsteroidal anti-inflammatory drug (NSAID), or their combination could effectively reduce opioid use in children after laparoscopic inguinal hernia repair. METHODS: This randomized, […]
Read MoreAuthors: Philip E. Bickler, M.D., Ph.D.et al Anesthesiology February 2021, Vol. 134, 262–269. The Coronavirus infection disease 2019 (COVID-19) pandemic is bringing unprecedented numbers of patients with significant hypoxemia to medical care. It is critical that clinicians caring for hypoxemic patients recognize two facts: (1) it is common for hypoxemia to exist without dyspnea (“silent hypoxia”); […]
Read MoreAuthors: Brian M. Ilfeld, M.D., M.S. et al Anesthesiology February 2021, Vol. 134, 283–344. The authors provide a comprehensive summary of all randomized, controlled trials (n = 76) involving the clinical administration of liposomal bupivacaine (Exparel; Pacira Pharmaceuticals, USA) to control postoperative pain that are currently published. When infiltrated surgically and compared with unencapsulated bupivacaine or […]
Read More